Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
genmab,abbvie
['lymsm']
100% orr across all subgroups and the highest cr i ve seen in 1l in pts completing 1-yr epcor-r-chop presented by falchi et al at #icml23 #lymsm 
Opinions are my own: Former GLG Council Member (Oncology, IO, CAR T)